From the Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
From the Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
Am J Ophthalmol. 2021 Jun;226:165-171. doi: 10.1016/j.ajo.2021.01.004. Epub 2021 Jan 22.
To evaluate repeat Descemet membrane endothelial keratoplasty (re-DMEK) success rates and to identify risk factors for re-DMEK failure.
Retrospective case series.
Settings: Institutional.
A chart review was performed, including all eyes with primary DMEK failure that underwent re-DMEK between 2013 and 2019 at the Toronto Western Hospital and the Kensington Eye Institute (Toronto, Ontario, Canada) and had at least 6 months of follow-up.
Predicting factors for re-DMEK outcome.
Of 590 consecutive DMEK surgeries, 40 eyes (6.7%) were identified for having a secondary DMEK surgery after primary DMEK failure. Etiologies for primary DMEK were Fuchs endothelial corneal dystrophy (32.5%), pseudophakic bullous keratopathy (35%), previous failed graft (27.5%), and other indications (5%). Fifty-five percent of the cohort were categorized as having a complicated anterior segment including 11 eyes with previous glaucoma surgery, 7 eyes post-penetrating keratoplasty, 4 eyes post-Descemet stripping automated endothelial keratoplasty, 3 eyes peripheral anterior synechia, 3 eyes previous pars plana vitrectomy, 2 eyes aphakia, and 1 eye each with aniridia, anterior chamber intraocular lens, and iris-fixated intraocular lens. Re-DMEK failure was documented in 12 eyes (30%) of the entire cohort. The risk factor for re-DMEK failure was the presence of a complicated anterior segment (P = .01, odds ratio = 17.0 [95% confidence interval: 1.92-150.85]), with 50% re-DMEK failure rate in this subgroup.
Re-DMEK is a viable option for cases of primary DMEK failure, especially for eyes with Fuchs endothelial corneal dystrophy as the indication for primary DMEK without other ocular morbidities; however, eyes categorized with a complicated anterior segment had high re-DMEK failure rates..
评估重复 Descemet 膜内皮角膜移植术(re-DMEK)的成功率,并确定 re-DMEK 失败的风险因素。
回顾性病例系列。
设置:机构内。
对 2013 年至 2019 年在多伦多西部医院和肯辛顿眼科研究所(加拿大安大略省多伦多)接受原发性 DMEK 失败后行 re-DMEK 并至少随访 6 个月的所有原发性 DMEK 失败患者进行了图表回顾。
预测 re-DMEK 结果的因素。
在 590 例连续 DMEK 手术中,有 40 只眼(6.7%)因原发性 DMEK 失败后行二次 DMEK 手术而被确定。原发性 DMEK 的病因包括 Fuchs 内皮角膜营养不良(32.5%)、假性晶状体性大泡性角膜病变(35%)、既往失败移植物(27.5%)和其他适应证(5%)。该队列的 55%被归类为存在复杂的前段,包括 11 只眼有既往青光眼手术史、7 只眼有穿透性角膜移植术后、4 只眼有 Descemet 膜撕除自动内皮角膜移植术后、3 只眼有周边前粘连、3 只眼有既往玻璃体切除术、2 只眼有无晶状体眼和 1 只眼分别有虹膜缺失、前房人工晶状体和虹膜固定人工晶状体。整个队列中有 12 只眼(30%)记录到 re-DMEK 失败。re-DMEK 失败的风险因素是存在复杂的前段(P =.01,优势比= 17.0 [95%置信区间:1.92-150.85]),在该亚组中 re-DMEK 失败率为 50%。
对于原发性 DMEK 失败的病例,re-DMEK 是一种可行的选择,特别是对于因 Fuchs 内皮角膜营养不良而接受原发性 DMEK 的病例,且无其他眼部病变;然而,被归类为复杂前段的眼睛 re-DMEK 失败率较高。